- China represents the biggest marketplace for child meals globally
- Human milk oligosaccharides are key for the event of a wholesome toddler microbiome
Hohhot, China & Rheinbreitbach, Germany – Jennewein Biotechnologie GmbH, the worldwide chief within the analysis and manufacture of human milk oligosaccharides (HMO), and Internal Mongolia Yili Industrial Group (Yili Group), China’s main dairy firm, announce right now the signing of a Memorandum of Understanding on toddler microbiome and human milk oligosaccharides, with the purpose to develop an revolutionary toddler method and dairy merchandise particularly tailor-made to the Chinese language market.
“After already having launched human milk oligosaccharides in different world areas, akin to the important thing U.S. market and chosen European international locations, we’re very excited to work with Yili, the home market chief for microbiome/child meals in China” said Dr. Stefan Jennewein, CEO and Co-Founding father of Jennewein Biotechnologie. “With 50% of the whole international market quantity (2021e: 76 billion US$) China is presently the biggest marketplace for child meals. We’re dedicated to bringing the advantages of human milk oligosaccharides for the event of a wholesome toddler microbiome to Chinese language mother and father and their youngsters.”
Human milk oligosaccharides (HMOs) represent the third largest element of breast milk and are distinctive to people in focus and structural variety. HMOs possess a number of physiological results; they confer safety in opposition to infectious ailments (e.g. noro viruses) and act as prebiotics for the event of the toddler microbiome. As we speak, it’s well known that the institution of a wholesome microbiome is vital for the general improvement of an toddler. Failure to help a pure or wholesome microbiome could doubtlessly result in weight problems, autism or allergy improvement along with different current points in toddler well being and improvement. Nevertheless, most toddler formulation don’t include HMOs as of right now.
Dr Gerrit Smit, managing director of Yili Innovation Heart Europe said: “Yili Group has been devoted to Chinese language breast milk composition research for years and has initiated the institution of a Chinese language Breast Milk Database. Yili has continuously introduced revolutionary merchandise to the market based mostly on scientific analysis, for instance Professional-Kido, and is wanting ahead to collaborating with Jennewein sooner or later.”
About HMOs:
Human milk oligosaccharides (HMOs) are advanced sugar molecules which are solely current in breast milk. They’re the third most plentiful constituent of human milk after lipids and lactose. Greater than 200 structurally totally different HMOs have been recognized. Essentially the most plentiful HMO is 2′-fucosyllactose, which is produced by about 80% of all lactating moms at concentrations of as much as 2 g/L. Scientific research have proven that HMOs, and a pair of′ fucosyllactose particularly, have a constructive affect on toddler improvement. HMOs are prebiotic, i.e. they particularly promote the expansion of useful microorganisms, and on the similar time they inhibit the expansion of pathogens. Jennewein Biotechnologie initially launched HMO 2′-fucosyllactose onto the worldwide child meals market in 2015.
About Jennewein Biotechnologie:
As a number one worldwide biotech firm, Jennewein Biotechnologie manufactures an intensive portfolio of revolutionary HMO merchandise (advanced human oligosaccharides (HMOs) and uncommon monosaccharides, akin to 2′ fucosyllactose, 3-fucosyllactose and lacto-N-tetraose. These uncommon sugars are used within the meals trade (notably toddler milk formulation), the pharmaceutical trade, and the beauty trade. The manufacturing course of entails state-of-the-art fermentation methods. The corporate is constructing one of many largest fermentation vegetation in Central Europe. In 2015, the US Meals and Drug Administration (FDA) granted Jennewein Biotechnologie a license to market 2′-fucosyllactose making it the primary firm to introduce the primary biotechnologically produced human oligosaccharide into the toddler feeding market in the US. This was adopted in 2017 by European Union authorisation beneath the Novel Meals Regulation. Jennewein Biotechnologie works with a lot of the international child meals firms, and several other toddler milk formulation around the globe now include 2′-fucosyllactose (e.g. Abbott Similac).
About Yili Industrial Group:
In keeping with Rabobank’s International Dairy Prime 20 record, Yili Group is the biggest dairy firm in Asia. Constantly rating as the highest dairy firm in China for years, Yili has essentially the most full product classes in Chinese language dairy trade. As the one Chinese language dairy firm that meets each the Olympic and the World Expo requirements, Yili has efficiently served the 2008 Beijing Olympic Video games and the 2010 Shanghai World Expo. Greater than 100 million Yili merchandise are delivered to customers every day, and greater than 37 billion Yili merchandise are offered annually, together with milk, yogurt, ice cream, and milk powder merchandise. By gathering international assets and constructing networks in superior dairy markets akin to Europe, North America, Oceania, and Asia, Yili has been continuously reaching R&D improvements. Beneath the company philosophy “Yili represents the very best high quality”, Yili has been advancing to grow to be essentially the most trustable wholesome meals supplier worldwide.
Media Contact:
Jennewein Biotechnologie
Dr. Bettina Gutierrez
[email protected]
02224/98810797
